Genomic Health has completed testing of its Oncotype SEQ Liquid Select, showing the liquid biopsy mutation panel to be sensitive, specific and reproducible.

Everyone has checked symptoms online, using websites such as WebMD, to help diagnose themselves, but are these kinds of computer diagnostics accurate—or at least better than an actual physician? Harvard Medical School student Hannah L. Semigran with researchers from Brigham and Women’s Hospital and the Human Diagnosis Project have good news for doctors.

Warnings for specific prescription drugs may not cover the implications of mixing certain medications, which can mean side effects much worse than just dizziness or upset stomach. While many of the dangerous drug parings have been discovered, many are still hidden. Researchers from New York's Columbia University Medical Center and the Data Science Institute at Columbia University are using data science to uncover such interactions.

As the fifth most common cancer in Europe, bladder cancer is one of the most expensive cancers to treat and have a high recurrence rate thus making the cost even higher. Cepheid has developed its Xpert Bladder Cancer Monitor to accurately provide information on cancer recurrence as a non-invasive and cost conscience option.

The topic of pain management is moving away from its current dependence on drugs into methods that incorporate therapy outside of medication. Omron Healthcare has introduced its Omron HEAT Pain Pro, which utilizes heat and transcutaneous electrical nerve stimulation (TENS) technology to treat joint and muscle pain.

Medtronic has received approval from the U.S. Food and Drug Administration (FDA) for a potentially revolutionary device that monitors glucose levels and delivers insulin automatically. The MiniMed 670G works as an “artificial pancreas," because its sensors constantly monitor insulin levels within the body and inject the dose needed accordingly.

The World Health Organization confirmed that both North and South America are free of endemic measles, the first region to be certified as such, according to a recent report from The New York Times.

GE Healthcare has launched its five.eight accelerator program for improving healthcare in developing countries. The program will assist healthcare startups in improving the quality and accessibility of healthcare technologies for patients otherwise unable to receive care.